Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV.
Saved in:
| Title: | Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV. |
|---|---|
| Authors: | Fey T; Comprehensive Cancer Center (CCC Munich LMU), Ludwig Maximilians University (LMU) Hospital, Munich, Germany., Erickson N; Comprehensive Cancer Center (CCC Munich LMU), Ludwig Maximilians University (LMU) Hospital, Munich, Germany. nicole.erickson@med.uni-muenchen.de., Stahler A; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany., Muenchhoff M; Max von Pettenkofer Institute & Gene Center, Virology, National Reference Center for Retroviruses, Ludwig Maximilians University München, Pettenkoferstr. 9a, 80336, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site, Munich, Germany., Keppler OT; Max von Pettenkofer Institute & Gene Center, Virology, National Reference Center for Retroviruses, Ludwig Maximilians University München, Pettenkoferstr. 9a, 80336, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site, Munich, Germany., Ruehlmann K; Comprehensive Cancer Center (CCC Munich LMU), Ludwig Maximilians University (LMU) Hospital, Munich, Germany., Krauss-Pfeiffer G; Comprehensive Cancer Center (CCC Munich LMU), Ludwig Maximilians University (LMU) Hospital, Munich, Germany., Steinberg H; Comprehensive Cancer Center (CCC Munich LMU), Ludwig Maximilians University (LMU) Hospital, Munich, Germany., Graf A; Laboratory for Functional Genome Analysis, Gene-Center, Ludwig Maximilians University, Munich, Germany., Krebs S; Laboratory for Functional Genome Analysis, Gene-Center, Ludwig Maximilians University, Munich, Germany., Blum H; Laboratory for Functional Genome Analysis, Gene-Center, Ludwig Maximilians University, Munich, Germany., Khatamzas E; Center for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany., Seynstahl S; Comprehensive Cancer Center (CCC Munich LMU), Ludwig Maximilians University (LMU) Hospital, Munich, Germany., Casuscelli J; Department of Urology, Ludwig Maximilians University (LMU) Hospital, Munich, Germany., Markwardt D; Department of Gastroenterology, Ludwig Maximilians University (LMU) Hospital, Munich, Germany., Forstpointner R; Department of Oncology and Hematology, Ludwig Maximilians University (LMU) Hospital, Munich, Germany., Schinköthe T; CANKADO Service GmbH, Cologne, Germany., von Bergwelt-Baildon M; Department of Oncology and Hematology, Ludwig Maximilians University (LMU) Hospital, Munich, Germany., Heinemann V; Comprehensive Cancer Center (CCC Munich LMU), Ludwig Maximilians University (LMU) Hospital, Munich, Germany.; Department of Oncology and Hematology, Ludwig Maximilians University (LMU) Hospital, Munich, Germany. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2022 Apr 10; Vol. 39 (6), pp. 104. Date of Electronic Publication: 2022 Apr 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
